Anew Medical, Inc. ( WENA ) shares are volatile Wednesday after the company signed a license agreement with Transfertech Sherbrooke for the Nanoject autoinjector for medicines and vaccines.

Nanoject is a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. The core delivery device “shoots” nano-sized or micron-sized particles of medicine at high speed into the skin for intradermal and subcutaneous tissue delivery.

Read Next: Microchip Technology Stock Dips After Cybersecurity Incident

Anew Medical's ( WENA ) stock soared in premarket trading following the announcement, however the stock has since given back much of the gains but is still up for the session. According to data from Benzinga Pro, more than 16 million shares have been traded in the session, compared to the stock’s 100-day average of 4.617 million shares.

How To Buy WENA Stock:

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Anew Medical's ( WENA ) case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

WENA Price Action: According to Benzinga Pro, Anew Medical ( WENA ) shares are up 12.1% at $1.15 at the time of publication Wednesday.

Read Also: What’s Going On With Nano Nuclear Energy Stock?

Image: Shutterstock